A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer (Q58819336)
Jump to navigation
Jump to search
scientific article published on 28 April 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer |
scientific article published on 28 April 2011 |
Statements
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer (English)
Pierre Major
Bindi Dhesy-Thind
Lisa Wang
Daniel J Renouf
Patricia A Tang
John R Goffin
L Doyle
Malcolm J Moore
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference